Clomiphene citrate response is predictable in corpus luteum insufficiency

In: European Journal of Obstetrics & Gynecology and Reproductive Biology · 1987 · vol. 24(1) , pp. 53–56 · doi:10.1016/0028-2243(87)90037-2 · PMID:3102293 · W2032559732
article OA: bronze CC0 ⤵ 2 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite, 2026-06-10

This study demonstrates that clomiphene citrate treatment response can be accurately predicted in patients diagnosed with corpus luteum insufficiency.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In order to predict the correct dose of clomiphene citrate in corpus luteum insufficiency, the results of the treatment of 117 patients were evaluated. Serum progesterone and prolactin concentrations were determined by RIA. A 3-fold increase in serum progesterone concentration was found following the 100 mg per day clomiphene citrate treatment, independently of the pretreatment progesterone or prolactin values. This means that in a well-selected, hormonally homogeneous group of patients, contrary to earlier observations, the clomiphene citrate sensitivity of the patients is predictable.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

References (5)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK